Keros Therapeutics, Inc. financial statements
Keros Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 243.86M | 10-K |
| Net income | USD 87.01M | 10-K |
| Cash and equivalents | USD 287.42M | 10-Q |
| Total debt | USD 16.88M | EODHD |
Keros Therapeutics, Inc. financials on 6ix · Keros Therapeutics, Inc. on 6ix